Myriad Genetics Inc (MYGN)

Equity Ratio

47.57%

Quarterly · Period ending:

MYGN logo

MYGN Equity Ratio

Latest reported47.57%
MYGN Quarterly Equity Ratio (93.27% → 47.57%)
High-resolution chart · PNG

MYGN equity ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Equity Ratio — Quarterly
Period endingEquity Ratio
47.5661%
50.0816%
52.0804%
51.2018%
57.301%
70.0626%
68.2269%
67.6685%
68.2426%
68.4376%
68.3123%
59.4726%
61.9272%
71.4273%
73.8967%
75.6271%
78.2846%
75.6811%
73.2793%
72.5054%
66.3457%
65.4649%
62.0172%
62.9491%
65.3709%
66.8556%
68.2506%
67.5277%
69.6807%
69.4664%
68.367%
70.0432%
82.2003%
77.8252%
74.416%
70.9029%
63.5619%
59.0156%
57.4328%
57.8724%
84.9631%
88.7123%
88.4249%
87.3062%
86.4135%
85.8608%
88.7942%
88.0278%
87.2785%
88.4639%
89.3337%
88.3087%
90.6413%
91.2076%
92.2499%
90.4%
92.0399%
93.27%
93.2713%
93.4261%
92.7909%
94.1107%
94.5237%
93.4957%
93.893%
96.2316%
95.7945%
95.7515%
93.1025%
94.1165%
90.6164%
89.8002%
85.2432%
90.367%
90.9225%
91.5307%
90.633%
93.6601%
89.9086%
91.2688%
90.3031%
92.2409%
91.7319%
85.1055%
85.3515%
89.7005%
89.87%
92.19%
91.9939%
89.9952%
91.7895%
92.6435%
89.4231%
92.9372%
89.0066%
88.5191%
81.879%
87.6803%
87.1909%
86.3738%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.